U.S. Markets closed

Exagen Inc. (XGN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.67+0.98 (+10.11%)
At close: 04:00PM EST
10.67 0.00 (0.00%)
After hours: 05:39PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.69
Bid8.50 x 1400
Ask13.86 x 1000
Day's Range9.60 - 10.99
52 Week Range8.75 - 24.67
Avg. Volume43,719
Market Cap180.625M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-72.27
Earnings DateMay 11, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.00
  • GlobeNewswire

    Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

    SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Piper Sandler 33rd Annual Virtual Healthcare Conference. From November 22nd to December 2nd, presentations will be available for registered attendees via the Piper Sandler conference site. Exagen will be participating in one-on-one meetings on December 1st. Meetings can be requested exclusively via Piper Sandler. Ron Rocca, Exagen’s

  • Motley Fool

    Exagen Inc. (XGN) Q3 2021 Earnings Call Transcript

    Earlier today, Exagen Inc. released financial results for the quarter ended September 30, 2021. Ron Rocca, president and chief executive officer; Kamal Adawi, chief financial officer; and Mark Hazeltine, chief operating officer, will host this afternoon's call.

  • Zacks

    Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates

    Exagen Inc. (XGN) delivered earnings and revenue surprises of 2.33% and 0.97%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?